Salicylhydroxamic acid: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
|info=[[Parrino_2000_J_Exp_Biol]] | |info=[[Parrino_2000_J_Exp_Biol]] | ||
}} | }} | ||
{{MitoPedia topics | {{MitoPedia topics | ||
|mitopedia topic=Inhibitor | |mitopedia topic=Inhibitor | ||
}} | }} | ||
== Application in [[ | == Application in [[HRR]] == | ||
'''SHAM: Salicylhydroxamic acid''' (99%; HOC<sub>6</sub>H<sub>4</sub>CONHOH); Sigma S 607, 5 g, store at | '''SHAM: Salicylhydroxamic acid''' (99%; HOC<sub>6</sub>H<sub>4</sub>CONHOH); Sigma S 607, 5 g, store at RT; FW = 153.14. |
Revision as of 13:26, 17 March 2019
Description
Salicylhydroxamic acid (SHAM; synonym: 2-Hydroxybenzohydroxamic acid N,2-Dihydroxybenzamide) is an inhibitor of alternative oxidases (AOX). When AOX is blocked by SHAM, electrons are forced through the cytochrome pathway and through cytochrome IV, allowing observation of the operation of the cytochrome pathway without AOX activity.
Abbreviation: SHAM
Reference: Parrino_2000_J_Exp_Biol
MitoPedia topics:
Inhibitor
Application in HRR
SHAM: Salicylhydroxamic acid (99%; HOC6H4CONHOH); Sigma S 607, 5 g, store at RT; FW = 153.14.